Professor Chan, Daniel Tak Mao 陳德茂
Professor Chan, Daniel Tak Mao 陳德茂
Professor Tak Mao Daniel Chan is currently Chair Professor, Yu Chiu Kwong Professor in Medicine and Chief of Nephrology Division in the Department of Medicine at the University of Hong Kong. He received his training in Nephrology and Internal Medicine at the University of Hong Kong and Guy’s Hospital, London, UK.
T M Chan’s research interests include:
- treatment and immuno-pathogenesis of lupus nephritis
- management of viral hepatitis in immunosuppressed patients with kidney diseases
The team is internationally recognized for their research output in lupus nephritis. In 2000 he published, in the New England Journal of Medicine, the first randomized controlled trial demonstrating the efficacy and tolerability of mycophenolate mofetil (MMF) in the treatment of severe lupus nephritis. Extended follow-up data from this investigator-initiated study was later published in the J Am Soc Nephrol (2005) and Rheumatology (Oxford) (2013). These results have subsequently been reconfirmed by other investigators and large-scale international multicenter studies, and MMF is now an established first-line standard of care treatment for lupus nephritis. The team has also investigated the potential of calcineurin inhibitors and proliferation signal inhibitors as novel treatments for lupus nephritis.
Their basic research on lupus nephritis pathogenesis focuses on the interaction of anti-dsDNA antibodies with resident renal cells. They discovered that human anti-dsDNA antibodies could bind to annexin II on the surface of mesangial cells. After binding to the cell surface these autoantibodies are internalized and translocated to the cell nucleus, where they mediate downstream inflammatory and fibrotic responses. Translational work is being done to investigate the mechanisms and approaches to intervene progressive renal fibrosis following active lupus nephritis. The results have been published in J Am Soc Nephrol, Arthritis Rheum, and Kidney Int.
The team was among the first in the early 1990s to describe the epidemiology and natural history of hepatitis C infection in dialysis patients and kidney transplant recipients, and is internationally recognized for their work in hepatitis B management in kidney transplant recipients. They showed that pre-emptive antiviral treatment markedly improved the survival of HBsAg+ kidney transplant recipients, and investigated the role of novel antiviral medications. These results have been published in Gastroenterology, Hepatology, Am J Transplant, and Transplantation. He is also an author for related chapters in UpToDate.
|Awardees||Award Date||Honours / Awards / Prizes||Category|
|2004-02-01||Emodin abrogates peritoneal dialysate induction of pro-inflammatory/fibrotic mediators and morphological changes in human peritoneal mesothelial cells: 9th Medical Research Conference||Research Achievement|
|1998-12-01||Asia Young Investigator Award||Research Achievement|
|2006-12-01||Outstandind Researcher Award, University of Hong Kong||Research Achievement|
|2001-06-01||Emodin ameliorates glucose-induced excess matrix synthesis by human peritoneal mesothelial cells: Peritoneal Dialysis International||Research Achievement|
|1997-12-01||Award for Quality in Service & Management (on behalf of the Renal Unit): Queen Mary Hospital||Others|
|1995-12-01||Sir Patrick Manson Gold Medal (MD thesis): The University of Hong Kong||Others|
|2005-02-01||Induction of IL-6 synthesis in proximal tubular epithelial cells by anti-DNA antibodies varies with lupus nephritis activity: 10th Medical Research Conference||Research Achievement|
|Term Period||Position||Professional Societies|
|since 2004||Member||Hong Kong College of Physicians Examinations Committee|
|since 2003||Executive Committee and Council Member||Asian Pacific Society of Nephrology|
|since 2000||Executive Committee and Council Member||Asian Society of Transplantation|
|since 2002||Honorary Secretary and Executive Committee Member||HKU Medical Alumni Association|
|since 2000||Programme Director and Board Member||Hong Kong College of Physicians Advanced Internal Medicine Board|
|since 1996||Member||Hospital Authority Central Renal Committee|
|since 2003||Member||Hospital Authority Training Subcommittee in Internal Medicine|
|since 1996||Programme Director and Board Member||Hong Kong College of Physicians Nephrology Board|
Are You Missing Publications, Invited Lectures? Click Me.